Retraction

PTBP1 as a Promising Predictor of Poor Prognosis by Regulating Cell Proliferation, Immunosuppression, and Drug Sensitivity in SARC

Citations (12)

12
Total Citations
7
Post-Retraction
(58.3%)
4
Pre-Retraction
1
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
6 Within 1 year
0 After 2+ years
560 Days since retraction (latest)
DCS, a novel classifier system based on disulfidptosis reveals tumor microenvironment heterogeneity and guides frontline therapy for clear cell renal carcinoma
Aimin Jiang, Wenqiang Liu, Ying Liu et al. (14 authors)
Journal of the National Cancer Center Open Access
Published: Jun 2024
4 citations
362 days after retraction
Cellular senescence induced by down-regulation of <i>PTBP1</i> correlates with exon skipping of mitochondrial related gene <i>NDUFV3</i>
Yu Yang, Haimei Wen, Yuxin Li et al. (7 authors)
Life Medicine Open Access
Published: Apr 2024
1 citation
285 days after retraction
RNA Binding Protein PTBP1 Promotes the Metastasis of Gastric Cancer by Stabilizing PGK1 mRNA
Xiaolin Wang, Ce Liang, Shimin Wang et al. (16 authors)
Cells Open Access
Published: Jan 2024
3 citations
205 days after retraction
A novel oncolytic virus-based biomarker participates in prognosis and tumor immune infiltration of glioma
Zheng Hao, Xiaofeng Yin, Rui Ding et al. (6 authors)
Frontiers in Microbiology Open Access
Published: Sep 2023
1 citation
93 days after retraction
Integrative analysis of TROAP with molecular features, carcinogenesis, and related immune and pharmacogenomic characteristics in soft tissue sarcoma
Chao Tu, Binfeng Liu, Chenbei Li et al. (8 authors)
MedComm Open Access
Published: Sep 2023
5 citations
89 days after retraction
Predictive value of micro-RNA expression profiling in pediatric desmoid fibromatosis
Mohamed Eid, Hanafy Hafez, Hend E. El-Shaqanqery et al. (13 authors)
Acta Oncologica Open Access
Published: Jul 2023
35 days after retraction
Retracted: PTBP1 as a Promising Predictor of Poor Prognosis by Regulating Cell Proliferation, Immunosuppression, and Drug Sensitivity in SARC
Oxidative Medicine And Cellular Longevity
Oxidative Medicine and Cellular Longevity Open Access
Published: Jun 2023
Same day as retraction
Epigenetic Changes Associated with Osteosarcoma: A Comprehensive Review
Luke Twenhafel, DiAnna Moreno, Trista Punt et al. (5 authors)
Cells Open Access
Published: Jun 2023
17 citations
12 days before retraction
Spatiotemporal expression of RNA-seq identified proteins at the electrode interface
Cort H. Thompson, Blake M. Evans, Dorothy X. Zhao et al. (4 authors)
Acta Biomaterialia Open Access
Published: Apr 2023
6 citations
55 days before retraction
LncRNA AC006064.4–201 serves as a novel molecular marker in alleviating cartilage senescence and protecting against osteoarthritis by destabilizing CDKN1B mRNA via interacting with PTBP1
Panyang Shen, Jun Gao, Shaohan Huang et al. (12 authors)
Biomarker Research Open Access
Published: Apr 2023
10 citations
69 days before retraction
A feedback loop between <scp>NONHSAT024276</scp> and <scp>PTBP1</scp> inhibits tumor progression and glycolysis in <scp>HCC</scp> by increasing the <scp>PKM1</scp>/<scp>PKM2</scp> ratio
Yuwei Li, Xia Chen, Hengliu Huang et al. (10 authors)
Cancer Science Open Access
Published: Dec 2022
8 citations
184 days before retraction
Quick Stats
Total Citations: 12
Years Since Retraction: 2.4 years
Open Access: Yes
Last Checked: Jul 24, 2025